Impact of Cytomegalovirus Disease in D+/R- Kidney Transplant Patients Receiving 6 Months Low-Dose Valganciclovir Prophylaxis
American Journal of Transplantation - United Kingdom
doi 10.1111/j.1600-6143.2011.03611.x
Full Text
Open PDFAbstract
Available in full text
Date
August 9, 2011
Authors
Publisher
Wiley